At a glance
ClinicalIndex Comparison RecordN/ACompleted· 73 enrolled
Drug / intervention
Endovascular Treatment (Zenith)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of the Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissection
In Brief
A clinical study evaluating Endovascular Treatment (Zenith) for Aortic Dissection. Completed, enrolled 73 participants across 24 sites in 2 countries.
Detailed Summary
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Dissection
CountriesJapan, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 2012
Enrollment StartAug 2012
Primary CompletionFeb 2015
Study CompletionJan 2020
TodayJul 2026
First PostedApr 2, 2012
Enrollment StartAug 1, 2012
Primary CompletionFeb 1, 2015
Study CompletionJan 27, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 14.3 years ago
Interventions
Endovascular Treatment (Zenith)device
Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.